| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 5,875,711 | $7,932,210 | $1.35 | 05 Jul 2022 | By Nutritional Health LTP Fund, L.P. |
| Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 5,825,495 | $7,864,418 | $1.35 | 05 Jul 2022 | By Flagship Pioneering Fund VII, L.P. |
| Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 4,434,600 | $5,986,710 | $1.35 | 05 Jul 2022 | By Flagship Ventures Fund IV, L.P. |
| Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 2,962,963 | $4,000,000 | $1.35 | 05 Jul 2022 | By Flagship Pioneering Fund VI, L.P. |
| Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 2,734,994 | $3,692,242 | $1.35 | 05 Jul 2022 | By Flagship VentureLabs IV LLC |
| Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 1,283,282 | $1,732,431 | $1.35 | 05 Jul 2022 | By Flagship Ventures Fund IV-Rx, L.P. |
| Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 376,018 | $507,624 | $1.35 | 05 Jul 2022 | By Noubar B. Afeyan, Ph.D. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | 05 Jul 2022 | 2 | +$27,525,465 | 4 | 10%+ Owner | 07 Jul 2022, 17:00 |
| MCRB | Seres Therapeutics, Inc. | 17 May 2021 | 1 | $0 | 4 | 10%+ Owner | 19 May 2021, 19:05 |